NEWAMSTERDAM PHARMA COMPANY (NAMSW) Stock Institutional Owners
NEWAMSTERDAM PHARMA COMPANY (NAMSW) is held by 2 institutional investors with a total value of $147.86M. This comprehensive analysis highlights the top institutional holders led by Viking Global Investors, Polen Capital Management, and others, who collectively account for nearly 100% of the total institutional ownership.Viking Global Investors remains the largest institutional holder with a position worth $147.46M. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- NEWAMSTERDAM PHARMA COMPANY (NAMSW) stock institutional trading activity
- NEWAMSTERDAM PHARMA COMPANY (NAMSW) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Viking Global Investors | Ole Andreas Halvorsen | 0.39% | 4,203,567 | $147,461,130 |
| Polen Capital Management | David M. Polen | 0.00% | 11,239 | $394,264 |
Frequently asked questions about NAMSW
Who owns the most NAMSW stock?
The largest holders of NAMSW are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NEWAMSTERDAM PHARMA COMPANY (NAMSW).
Is NAMSW widely held by superinvestors?
Many widely followed stocks like NAMSW appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NAMSW is represented among the institutional managers we track.